Pharmaceutical Product Development Inc. (PPDI) reported that its fourth-quarter net income decreased to $18.991 million or $0.16 per share from $47.200 million or $0.40 per share last year.
On average, 11 analysts polled by Thomson Reuters expected the company to report profit of $0.23 per share for the quarter. Analysts' estimates typically exclude special items.
Total net revenue decreased to $357.402 million from $363.139 million a year ago. Analysts expected revenue of $314.33 million for the quarter.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.